This site is for customers in Japan. Customers in other regions, please go to Global page.
HOME > Product search results > Code No. TS-M025-2 T-Select HLA-A*24:02 survivin-2B Tetramer-AYACNTSTL-APC

Code No. TS-M025-2

T-Select HLA-A*24:02 survivin-2B Tetramer-AYACNTSTL-APC

Price

¥190,000

Availability (in Japan)

0
(Contact us)

(In Japan at 17:00,
Jan 28, 2020 in JST)

Size

50 tests

Class Class I Animal species Human
Category cancer
Conjugate APC
Immunogen (Antigen) survivin-2B
Sequence AYACNTSTL
MHC Allele A*24:02
Location (aa) 80-88 Storage temp. 4°C Manufacturer MBL
Background Survivin is a member of the inhibitor of apoptosis protein (IAP) family and is functionally involved in both inhibition of apoptosis and regulation of cell division. There are five different isoforms which include the wild-type survivin, survivin-2B, surv
Related products TS-M025-1 T-Select HLA-A*24:02 survivin-2B Tetramer-AYACNTSTL-PE
TS-M025-P HLA-A*24:02 survivin-2B Peptide
TS-M085-1 HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-PE
TS-M085-2 HLA-A*02:01 Survivin (T2M) Tetramer-LMLGEFLKL-APC
Citations
  1. Kameshima H, et al., Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients. Cancer Sci. 102: 1181?|1187 (2011)(PMID:21371173)
  1. Miyazaki A, et al., Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer. Cancer Sci. 102: 324?|329 (2011)(PMID:21143701)
Product category
Cancer
Research area
Immunology
Cancer
Tools
MHC tetramer
この製品に関するお問い合わせをする

  • The availability is based on the information in Japan at 17:00, Jan 28, 2020 in JST.
  • The special price is shown in red color.
  • Please note that products cannot be ordered from this website. To purchase the items listed in this website, please contact us or local distributers.
  • For storage temparature: RT: room temparature
  • Please note that products in this website might be changed or discontinued without notification in advance for quality improvement.